TIG3: An important regulator of keratinocyte proliferation and survival

Journal of Investigative Dermatology

Volumn 134, Issue 7, 2014, Pages 1811-1816

  Scharadin, Tiffany M ^a   Eckert, Richard L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLATHRIN HEAVY CHAIN; CYTOKERATIN 1; CYTOKERATIN 10; ELAFIN; ENHANCED GREEN FLUORESCENT PROTEIN; FILAGGRIN; GAMMA TUBULIN; INVOLUCRIN; KERATIN; LECITHIN RETINOL ACYLTRANSFERASE; LORICRIN; PERICENTRIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SOMATOMEDIN B RECEPTOR; TIG3 PROTEIN; TRANSGLUTAMINASE 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; BASAL CELL; CANCER CELL; CELL DIFFERENTIATION; CELL DIVISION; CELL FUNCTION; CELL JUNCTION; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CENTROSOME; CROSS LINKING; EPIDERMIS; HUMAN; KERATINOCYTE; MICROTUBULE ASSEMBLY; MITOSIS SPINDLE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PSORIASIS; REVIEW; SKIN CANCER; TRANSFORMED CELL;

ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; KERATINOCYTES; PSORIASIS; RECEPTORS, RETINOIC ACID; SKIN NEOPLASMS;

EID: 84902548008     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.79     Document Type: Review

References (43)

1. Anantharaman V, Aravind L (2003) Evolutionary history, structural features and biochemical diversity of the NlpC/P60 superfamily of enzymes. Genome Biol 4:R11
2. Chakravarty R, Rice RH (1989) Acylation of keratinocyte transglutaminase by palmitic and myristic acids in the membrane anchorage region. J Biol Chem 264: 625-9
3. Dammermann A, Merdes A (2002) Assembly of centrosomal proteins and microtubule organization depends on PCM-1. J Cell Biol 159: 255-255
4. Delgehyr N, Sillibourne J, Bornens M (2005) Microtubule nucleation and anchoring at the centrosome are independent processes linked by ninein function. J Cell Sci 118: 1565-75
5. Deucher A, Nagpal S, Chandraratna RA et al. (2000) The carboxy-terminal hydrophobic domain of TIG3, a class II tumor suppressor protein, is required for appropriate cellular localization and optimal biological activity. Int J Oncol 17: 1195-203
6. DiSepio D, Ghosn C, Eckert RL et al. (1998) Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene. Proc Natl Acad Sci USA 95: 14811-5
7. Dixit R, Barnett B, Lazarus JE et al. (2009) Microtubule plus-end tracking by CLIP-170 requires EB1. Proc Natl Acad Sci USA 106: 492-7
8. Doxsey S, Zimmerman W, Mikule K (2005) Centrosome control of the cell cycle. Trends Cell Biol 15: 303-11
9. Duvic M, Helekar B, Schulz C et al. (2000) Expression of a retinoid-inducible tumor suppressor, tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer. Clin Cancer Res 6: 3249-59
10. Duvic M, Nagpal S, Asano AT et al. (1997) Molecular mechanisms of tazarotene action in psoriasis. J Am Acad Dermatol 37:S18-24
11. Duvic M, Ni X, Talpur R et al. (2003) Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application. J Invest Dermatol 121: 902-9
12. Eckert RL, Crish JF, Robinson NA (1997) The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol Rev 77: 397-424
13. Eckert RL, Sturniolo MT, Jans R et al. (2009) TIG3: a regulator of type I transglutaminase activity in epidermis. Amino Acids 36: 739-46
14. Gundersen GG, Khawaja S, Bulinski JC (1987) Postpolymerization detyrosination of alpha-tubulin: a mechanism for subcellular differentiation of microtubules. J Cell Biol 105: 251-64
15. Hajnal A, Klemenz R, Schafer R (1994) Subtraction cloning of H-rev107, a gene specifically expressed in H-ras resistant fibroblasts. Oncogene 9: 479-90
16. Hammond JW, Cai D, Verhey KJ (2008) Tubulin modifications and their cellular functions. Curr Opin Cell Biol 20: 71-6
17. Higuchi E, Chandraratna RA, Hong WK et al. (2003) Induction of TIG3, a putative class II tumor suppressor gene, by retinoic acid in head and neck and lung carcinoma cells and its association with suppression of the transformed phenotype. Oncogene 22: 4627-35
18. Huang SL, Shyu RY, Yeh MY et al. (2000) Cloning and characterization of a novel retinoid-inducible gene 1(RIG1) deriving from human gastric cancer cells. Mol Cell Endocrinol 159: 15-24
19. Huang SL, Shyu RY, Yeh MY et al. (2002) The retinoid-inducible gene I: effect on apoptosis and mitogen-activated kinase signal pathways. Anticancer Res 22: 799-804
20. Husmann K, Sers C, Fietze E et al. (1998) Transcriptional and translational downregulation of H-REV107, a class II tumour suppressor gene located on human chromosome 11q11-12. Oncogene 17: 1305-12
21. Ikegami K, Setou M (2010) Unique post-translational modifications in specialized microtubule architecture. Cell Struct Funct 35: 15-22
22. Jahng WJ, Xue L, Rando RR (2003) Lecithin retinol acyltransferase is a founder member of a novel family of enzymes. Biochemistry 42: 12805-12
23. Jans R, Sturniolo MT, Eckert RL (2008) Localization of the TIG3 transglutaminase interaction domain and demonstration that the amino-terminal region is required for TIG3 function as a keratinocyte differentiation regulator. J Invest Dermatol 128: 517-29
24. Jaworski J, Hoogenraad CC, Akhmanova A (2008) Microtubule plus-end tracking proteins in differentiated mammalian cells. Int J Biochem Cell Biol 40: 619-37
25. Jiang SY, Wu MS, Chen LM et al. (2005) Identification and characterization of the retinoic acid response elements in the human RIG1 gene promoter. Biochem Biophys Res Commun 331: 630-9
26. Kawakami S, Suzuki S, Yamashita F et al. (2006) Induction of apoptosis in A549 human lung cancer cells by all-trans retinoic acid incorporated in DOTAP/cholesterol liposomes. J Control Release 110: 514-21
27. Lechler T, Fuchs E (2007) Desmoplakin: an unexpected regulator of microtubule organization in the epidermis. J Cell Biol 176: 147-54
28. Lim HH, Zhang T, Surana U (2009) Regulation of centrosome separation in yeast and vertebrates: common threads. Trends Cell Biol 19: 325-33
29. Mogensen MM, Malik A, Piel M et al. (2000) Microtubule minus-end anchorage at centrosomal and non-centrosomal sites: the role of ninein. J Cell Sci 113(Pt 17): 3013-23
30. Ou CC, Hsu SC, Hsieh YH et al. (2008) Downregulation of HER2 by RIG1 involves the PI3K/Akt pathway in ovarian cancer cells. Carcinogenesis 29: 299-306
31. Phillips MA, Qin Q, Mehrpouyan M et al. (1993) Keratinocyte transglutaminase membrane anchorage: analysis of site-directed mutants. Biochemistry 32: 11057-63
32. Piehl M, Tulu US, Wadsworth P et al. (2004) Centrosome maturation: measurement of microtubule nucleation throughout the cell cycle by using GFP-tagged EB1. Proc Natl Acad Sci USA 101: 1584-8
33. Pincelli C, Marconi A (2010) Keratinocyte stem cells: friends and foes. J Cell Physiol 225: 310-5
34. Quinones GB, Danowski BA, Devaraj A et al. (2011) The posttranslational modification of tubulin undergoes a switch from detyrosination to acetylation as epithelial cells become polarized. Mol Biol Cell 22: 1045-1045
35. Scharadin TM, Adhikary G, Shaw K et al. (2014) Pericentrosomal localization of the TIG3 tumor suppressor requires an N-terminal hydrophilic region motif. J Invest Dermatol; e-pub ahead of print 9 January 2014
36. Scharadin TM, Jiang H, Jans R et al. (2011) TIG3 tumor suppressor-dependent organelle redistribution and apoptosis in skin cancer cells. PLoS One 6:e23230
37. Scharadin TM, Jiang H, Martin S et al. (2012) TIG3 interaction at the centrosome alters microtubule distribution and centrosome function. J Cell Sci 125: 2604-14
38. Simmons DP, Peach ML, Friedman JR et al. (2006) Evidence that sequence homologous region in LRAT-like proteins possesses anti-proliferative activity and DNA binding properties: translational implications and mechanism of action. Carcinogenesis 27: 693-707
39. Sturniolo MT, Chandraratna RA, Eckert RL (2005) A novel transglutaminase activator forms a complex with type 1 transglutaminase. Oncogene 24: 2963-72
40. Sturniolo MT, Dashti SR, Deucher A et al. (2003) A novel tumor suppressor protein promotes keratinocyte terminal differentiation via activation of type I transglutaminase. J Biol Chem 278: 48066-73
41. Talpur R, Cox K, Duvic M (2009) Efficacy and safety of topical tazarotene: a review. Expert Opin Drug Metab Toxicol 5: 195-210
42. Tsai FM, Shyu RY, Jiang SY (2007) RIG1 suppresses Ras activation and induces cellular apoptosis at the Golgi apparatus. Cell Signal 19: 989-99
43. Wilhelmus MM, de JM, Rozemuller AJ et al. (2011) Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies. J Pathol 226: 132-42